Challenges in HIV and visceral Leishmania co-infection: future research directions.
Ejara
Ermias Diro
ED
Lynen
Lutgarde
L
Boelaert
Marleen
M
Van Griensven
Johan
J
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000628:therapy; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D015897:Comorbidity; D005544:Forecasting; D015658:HIV Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
D044966:Anti-Retroviral Agents; D000981:Antiprotozoal Agents; D015415:Biomarkers